Related Experiment Video

Updated: Apr 11, 2026

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors
07:57

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors

Published on: January 20, 2023

7.3K

When Cancer Fights Back: Multiple Myeloma, Proteasome Inhibition, and the Heat-Shock Response

Shardule P Shah1, Sagar Lonial1, Lawrence H Boise2

  • 1Department of Hematology and Medical Oncology, Winship, Cancer Institute of Emory University and the Emory University School of Medicine, Atlanta, Georgia.

Molecular Cancer Research : MCR
|May 28, 2015
PubMed

Insights

Targeting heat-shock factor 1 (HSF1) may enhance proteasome inhibitor (PI) therapies for multiple myeloma. Understanding HSF1 regulation offers new strategies to overcome treatment resistance in this plasma cell malignancy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Multiple myeloma is a plasma cell malignancy with significant mortality.
  • Current therapies like proteasome inhibitors (PI) and immunomodulatory drugs (IMiD) improve survival but rarely achieve cure.
  • Resistance to therapy remains a major challenge in multiple myeloma treatment.

Purpose of the Study:

  • To review the regulatory mechanisms of heat-shock factor 1 (HSF1).
  • To explore the potential of targeting HSF1 to overcome therapeutic resistance in multiple myeloma.
  • To enhance the efficacy of proteasome inhibitor (PI)-based therapies.

Main Methods:

  • Review of existing literature on HSF1 regulation and its role in cancer.
  • Analysis of HSF1's function in cellular stress response pathways.
  • Discussion of posttranslational modifications (PTMs) controlling HSF1 activation.

Main Results:

  • HSF1 is a master regulator of the heat-shock response, crucial for proteotoxic stress.
  • HSF1 activation is tightly controlled by PTMs.
  • The cytoprotective heat-shock response mediated by HSF1 contributes to resistance against PI therapies.

Conclusions:

  • Targeting HSF1 and its regulatory pathways presents a promising strategy to enhance PI efficacy.
  • Understanding HSF1 mechanisms can lead to novel therapeutic approaches for multiple myeloma.
  • Interfering with HSF1-mediated cytoprotection may improve long-term outcomes for myeloma patients.

More Related Videos

Intracellular Refolding Assay07:18

Intracellular Refolding Assay

Published on: January 24, 2012

14.9K
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

14.0K

Related Concept Videos

Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.2K
Other Stress Responses in Bacteria01:30

Other Stress Responses in Bacteria

Bacteria have global regulatory systems that control several types of stress mechanisms. These include Pho regulon and the heat shock response, which are essential systems for environmental adaptation, such as nutrient limitation and proteotoxic stress. The Pho regulon and the heat shock response exemplify bacterial resilience, enabling rapid adaptation to fluctuating environmental conditions.Pho RegulonBacteria require phosphorus for essential cellular processes, including nucleic acid...
536
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
2.0K
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.7K
The Proteasome02:18

The Proteasome

5.1K
Bacterial Protein Maturation01:26

Bacterial Protein Maturation

Bacterial protein maturation is a tightly regulated process that ensures newly synthesized polypeptides achieve correct functional conformations. This maturation involves a series of modifications, folding events, and quality control steps, often assisted by specialized chaperone proteins.N-Terminal ModificationsThe maturation of bacterial polypeptides begins cotranslationally as the polypeptide exits the ribosome. The first amino acid, N-formylmethionine (fMet), is typically modified at the...
713